Edgewood Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,666
Closed -$23.2K 81
2023
Q3
$23.2K Sell
16,666
-1
-0% -$1 ﹤0.01% 79
2023
Q2
$60.2K Buy
+16,667
New +$60.2K ﹤0.01% 81